Melbourne, Australia-based animal therapeutics developer Nexvet Biopharma scored $31.5 million in a funding round from investors and shareholders to expand its product portfolio and clinical program for pets' health.
Farallon Capital Management LLC
Breaking News
Farallon Capital Management LLC acquired 9.91% stake from Nathan Tinkler making the fund the largest shareholder at Whitehaven Coal Ltd.
